Korea’s Green Cross Gains KFDA Approval For Biobetter of Shire's Elaprase
This article was originally published in PharmAsia News
Executive Summary
Encouraged by KFDA approval of its Elaprase biobetter, Green Cross is gearing up for an entry in China.